SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Antonia Hook

Research Associate

Antonia Hook

Antonia is part of the process development team working on the platform for upstream and downstream VLP production and purification. She also works on the development of new VLP clones.

Antonia joined SpyBiotech in 2021 from Oxgene where she worked on process development and scale up of viral vectors for gene therapy.

She holds a degree in Biomedical Sciences from the university of Reading.

Back to team

Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline